McDonnell M J, Anwar G A, Rutherford R M, De Soyza A, Worthy S, Corris P A, Lordan J L, Bourke S, Afolabi G, Ward C, Middleton P, Middleton D
Applied Immunobiology and Transplantation Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle, UK; Department of Respiratory Medicine, Galway University Hospitals, Galway, Ireland.
Department of Respiratory Medicine, Northumbria Healthcare Trust, Newcastle, UK.
Respir Med. 2014 Aug;108(8):1127-33. doi: 10.1016/j.rmed.2014.05.017. Epub 2014 Jun 18.
Idiopathic bronchiectasis is a poorly defined disease characterised by persistent inflammation, infection and progressive lung damage. Natural killer (NK) cells provide a major defense against infection, through the interaction of their surface receptors, including the activating and inhibitory killer immunoglobulin-like receptors (KIR), and human leukocyte antigens (HLA) class I molecules. Homozygosity for HLA-C has been shown in a single study to confer increased genetic susceptibility to idiopathic bronchiectasis. We aimed to assess whether the KIR and HLA repertoire, alone or in combination, may influence the risk of developing idiopathic bronchiectasis, in an independent replication study.
In this prospective, observational, case-control association study, 79 idiopathic bronchiectasis patients diagnosed following extensive aetiological investigation were compared with 98 anonymous, healthy, age, sex and ethnically-matched controls attending blood donor sessions in the same geographical location. DNA extraction was performed according to standardised techniques. Determination of presence or absence of KIR genes was performed by a sequence specific oligonucleotide probe method. Allele frequencies for the proposed KIR, HLA-B and HLA-C risk alleles both individually and in combinations were compared.
We found no significant differences in allele frequency between the idiopathic bronchiectasis and control samples, whether considering HLA-C group homozygosity alone or in combination with the KIR type.
Our results do not show an association between HLA-C and KIR and therefore do not confirm previous positive findings. This may be explained by the lower frequency of HLA-C1 group homozygosity in the control population of the previous study (27.2%), compared to 42.3% in our study, which is consistent with the genetic profiling of control groups across the UK. The previous positive association study may therefore have been driven by an anomalous control group. Further larger prospective multicentre replication studies are needed to determine if an association exists.
特发性支气管扩张是一种定义不明确的疾病,其特征为持续炎症、感染和进行性肺损伤。自然杀伤(NK)细胞通过其表面受体(包括激活型和抑制型杀伤免疫球蛋白样受体(KIR))与人白细胞抗原(HLA)I类分子的相互作用,提供主要的抗感染防御。一项研究表明,HLA - C纯合性会增加特发性支气管扩张的遗传易感性。在一项独立的重复研究中,我们旨在评估KIR和HLA谱单独或联合是否会影响特发性支气管扩张的发病风险。
在这项前瞻性、观察性、病例对照关联研究中,将79例经过广泛病因调查后确诊的特发性支气管扩张患者与98名在同一地理位置参加献血活动的匿名、健康、年龄、性别和种族匹配的对照者进行比较。按照标准化技术进行DNA提取。通过序列特异性寡核苷酸探针法确定KIR基因的有无。比较了所提议的KIR、HLA - B和HLA - C风险等位基因单独及联合的等位基因频率。
无论是单独考虑HLA - C组纯合性还是与KIR类型联合考虑,我们发现特发性支气管扩张样本与对照样本之间的等位基因频率均无显著差异。
我们的结果未显示HLA - C与KIR之间存在关联,因此未证实先前的阳性发现。这可能是因为与我们研究中的42.3%相比,先前研究的对照人群中HLA - C1组纯合性频率较低(27.2%),这与英国对照人群的基因谱一致。因此,先前的阳性关联研究可能是由异常的对照组驱动的。需要进一步开展更大规模的前瞻性多中心重复研究来确定是否存在关联。